Live feed
Filing
SC 13D/A
SC 13D/A0000899140-22-000118·Entasis Therapeutics Holdings Inc.
Schedule 13D ownership disclosure
Armata Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 04216R102
Event date: 2022-02-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 57,345,794
- Percent of class
- 75.1500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-22-000118
- Form type
- SC 13D/A
- Filer
- Entasis Therapeutics Holdings Inc.
- CIK
- CIK 1724344
- Filed
- Feb 02, 2022
- Reporting period
- Feb 01, 2022
- Description
- Schedule 13D beneficial ownership